US › Healthcare

Quidel Corporation (QDEL)

US · Healthcare · Medical Devices

$17.58-0.73%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$619.8M
Revenue YoY
-10.5%
Net profit
$-91.8M
Profit YoY
-622.8%
EPS
$-0.04
EPS estimate
$0.36
Net margin
-14.8%

EPS came in at -0.04 against a street estimate of 0.36 — a miss of 111.1%.

Key statistics

Market cap
$1.14B
Forward P/E
7.2
P/B
0.62
Book value
$27.19
EPS (TTM)
$-17.85
52-week high
$35.58
52-week low
$9.92
50-day MA
$15.22
200-day MA
$20.86
Beta
0.69

Analyst view

Analysts rate Quidel Corporation a buy (5 buy, 2 hold, 1 sell out of 8) with an average price target of $21.33.

Shareholding

Insiders
0.90%
Institutions
128.43%

Largest institutional holders

FundStake
BlackRock Inc15.32%
FMR Inc9.67%
T. Rowe Price Investment Management,Inc.8.26%
Newtyn Management LLC6.68%
Vanguard Portfolio Management, LLC5.91%
Rubric Capital Management LP4.85%
Amvescap Plc.4.57%
Vanguard Capital Management, LLC4.48%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Quidel Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.